The Food and Drug Administration just approved a needle-free treatment for hypoglycemia for people with diabetes.
The FDA said it approved Baqsimi nasal powder as emergency treatment of severe hypoglycemia. The department said hypoglycemia occurs in those with diabetes who are using insulin treatment.
The FDA approved the powder to treat the condition in patients ages 4 and older.
Baqsimi is administered into the nose and will come in a single-use dispenser that can be given to someone having a severe low blood sugar episode. The powder increases blood sugar levels by stimulating the liver to release glucose into the bloodstream.
The FDA said the powder has the opposite effect of insulin, which lowers blood sugar levels.
AptarGroup on Thursday said the FDA approved it Unidose Powder System for hypoglycemia treatment. Aptar is the company behind the device that will deliver the powder into a patient's nose.
- Coroner ruled man died of natural causes, but then the funeral home found stab wounds
- Florida correctional officers charged after video shows inmate being beaten
- Defense for former FSU student accused of killing parents continues to claim insanity
- Sleeping husband 'crumples' in pain after wife grabs him for sex: deputies
- St. Pete unveils aggressive affordable housing plan
►Make it easy to keep up-to-date with more stories like this. Download the 10News app now.
Have a news tip? Email desk@wtsp.com, or visit our Facebook page or Twitter feed.
